首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿德福韦酯对慢性乙型肝炎患者外周血T淋巴细胞亚群的影响
引用本文:王昕红,张光文,孙立华,魏晓霞.阿德福韦酯对慢性乙型肝炎患者外周血T淋巴细胞亚群的影响[J].中国现代医生,2010,48(20):53-54.
作者姓名:王昕红  张光文  孙立华  魏晓霞
作者单位:新乡医学院第一附属医院感染病科,河南新乡,453100
摘    要:目的探讨阿德福韦酯抗病毒治疗对慢性乙型肝炎患者外周血T淋巴细胞亚群的影响。方法选择41例慢性乙型肝炎患者,均给予阿德福韦酯10mg,每日1次,共48周,检测治疗前、治疗12个月患者外周血T淋巴细胞亚群。结果经抗病毒治疗后,患者血清HBV DNA滴度明显下降,T淋巴细胞亚群失衡改善,CD4+T淋巴细胞上升,CD4+/CD8+上升,较治疗前明显提高,差异有统计学意义(P0.05)结论慢性乙型肝炎患者经阿德福韦酯抗病毒治疗后抑制HBV的复制,其外周血T淋巴细胞亚群的状态呈逐渐改善趋势。

关 键 词:阿德福韦酯  慢性乙型肝炎  T淋巴细胞亚群

Effect of Adefovir Diivoxil on T Lymhocyte Subsetes in Chronic Hepatitis B
Authors:WANG Xinhong  ZHANG Guangwen  SUN Lihua  WEI Xiaoxia
Institution:(Department of Infectious Disease, the First Affiliated Hosital of Xinxiang Medical Collage, Xinxiang 453100,China)
Abstract:Objective To observe the effect of adefovir diivoxil on T lymhocyte subsetes in the treatment of chronic hepatitis B. Methods Forty-one cases of chronic heatitis B were treated with adefovir diivoxil 10 mg/d for 48 weeks. The peripheral blood T lymhocyte subsetes were analyzed before and after 12 month treatment. Results The serum HBV DNA titre was obviously decreased and the peripheral blood CD4+ T lymhocyte subsetes and the CD4+/CD8+ ratio were increased after treatment compared with pre-treatment, with a significant difference (P〈0.05 or 0.01). Conclusion Adefovir diivoxil can inhibit the HBV replication in chronic hepatitis B, with gradually improvement of peripheral blood T lymhocyte subsetes.
Keywords:Adefovir diivoxil  Chronic hepatitis B  T lymhocyte subsetes
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号